cnolan

Rib-X Pharmaceuticals Inc., a New Haven, Conn.-based pharmaceutical developer, has filed plans for an initial public offering to raise up to $80 million. The company had previously raised capital from investors including Warburg Pincus, ABS Ventures, Axiom Ventures, EuclidSR Partners, MedImmune Ventures, Oxford Bioscience Partners and S.R. One. Deutsche Bank Securities will act as the sole book-running manager for the offering. William Blair & Company, Lazard Capital Markets and Needham & Co. will act as co-managers.

CVC Capital Asia has sold shoe repair company Minit Asia Pacific to Japan's Unison Capital, Reuters reported. Minit Asia provides services for repairing shoes and bags. The sale is CVC Capital’s third attempt to sell the company, Reuters wrote.

China Development Bank Corp. is setting up an overseas investment platform and forming a partnership with private equity firms TPG Capital and Kohlberg Kravis Roberts & Co., Reuters reported over the weekend, citing the official China Daily.

Terra Firma Capital Partners is seeking to raise up to 1 billion euros ($1.33 billion) from a sovereign wealth fund so it can continue to do deals when its buy-out fund's investment period expires next year, Reuters reported, citing the Financial Times. The buy-out group has up to 700 million euros available for new investment in its third fund.

Mobile operator Hutchison 3G is offering 1.4 billion euros ($1.87 billion) to buy larger rival Orange Austria, Reuters reported Friday. France Telecom owns 35% of Orange Austria, and private equity firm Mid Europa Partners owns the other 65%.

South Korea's Hyundai Heavy Industries and Daewoo Shipbuilding & Marine Engineering are each mulling bids for French engineering company GTT, Reuters reported Tuesday. The potential bids are estimated at about 1 billion euro ($1.3 billion). GTT's three shareholders -- GDF Suez, the world's biggest utility by market value, French oil company Total and U.S. private equity fund Hellman & Friedman -- are planning to sell their stakes, Reuters wrote.

A group led by JH Partners and the Highland Consumer Fund is acquiring a majority interest in J.McLaughlin, the company announced Tuesday. The Brooklyn-based clothing brand has 52 stores across the Eastern U.S. Terms of the deal were not released.

Aligned Asset Managers, a portfolio company of private equity firm GTCR, has completed its investment in The Townsend Group. Townsend is a specialty real estate advisory and investment firm. Aligned purchased a majority equity interest in Townsend, though specific terms were not released.

Toll Brothers Inc. has entered the Seattle market with the acquisition of CamWest Development, a privately held home building company. Terms of the deal were not released, though Toll Brothers said that the acquisition was a cash deal.

Pfizer Inc. is buying Excaliard Pharmaceuticals Inc. for an undisclosed amount. Excaliard develops drugs for the treatment of skin fibrosis. Excaliard Pharmaceuticals previously raised venture financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners.